BF
ABBV icon

Brogan Financial’s AbbVie ABBV Stock Holding History

Brogan Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839K Buy
3,334
+251
+8% +$54K 0.34% 16
2026
Q1 		$671K Sell
3,083
-29
-0.9% -$6.43K 0.29% 21
2025
Q4 		$711K Buy
3,112
+22
+0.7% +$5.01K 0.31% 17
2025
Q3 		$715K Buy
3,090
+74
+2% +$15.1K 0.3% 16
2025
Q2 		$560K Sell
3,016
-182
-6% -$33.8K 0.25% 23
2025
Q1 		$670K Buy
3,198
+234
+8% +$45.5K 0.33% 18
2024
Q4 		$527K Buy
2,964
+28
+1% +$5.15K 0.26% 21
2024
Q3 		$580K Buy
2,936
+23
+0.8% +$4.29K 0.33% 21
2024
Q2 		$500K Buy
2,913
+27
+0.9% +$4.47K 0.31% 21
2024
Q1 		$526K Sell
2,886
-887
-24% -$153K 0.35% 20
2023
Q4 		$585K Buy
3,773
+40
+1% +$5.83K 0.43% 16
2023
Q3 		$556K Hold
3,733
– – 0.49% 15
2023
Q2 		$503K Hold
3,733
– – 0.43% 15
2023
Q1 		$595K Hold
3,733
– – 0.51% 14
2022
Q4 		$603K Buy
+3,733
New +$572K 0.54% 14

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brogan Financial's ABBV Position: Q2 2026 in Review

Brogan Financial increased its AbbVie (ABBV) stake by 8.1% in Q2 2026, buying an estimated $54K and bringing the position to 3,334 shares worth $839K. The position accounts for 0.34% of the portfolio, ranked #16.

Brogan Financial first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brogan Financial held 3,334 shares of AbbVie worth $839K as of Q2 2026.
  • Brogan Financial bought 251 AbbVie shares in Q2 2026, an estimated $54K.
  • AbbVie made up 0.34% of Brogan Financial's portfolio in Q2 2026, its #16 holding.
  • Brogan Financial first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brogan Financial's 13F filing for Q2 2026, filed 13 Aug 2026.